SLC6A19 is a system B(0) transporter that mediates epithelial resorption of neutral amino acids across the apical membrane in the kidney and intestine.[6][7]
^Bröer S (January 2008). "Amino acid transport across mammalian intestinal and renal epithelia". Physiological Reviews. 88 (1): 249–286. doi:10.1152/physrev.00018.2006. PMID18195088.
Lee SY, Kim YD, Do E, Kwon J, Kim S, Chu I, et al. (Oct 2008). "Minisatellite polymorphisms of the SLC6A19: susceptibility in hypertension". Biochemical and Biophysical Research Communications. 374 (4): 714–719. doi:10.1016/j.bbrc.2008.07.094. PMID18671945.
Kowalczuk S, Rodgers H, Auray-Blais C, Giguère R, Rasko JE, Bröer S, et al. (Oct 2008). "Further evidence for allelic heterogeneity in Hartnup disorder". Human Mutation. 29 (10): 1217–1221. doi:10.1002/humu.20777. PMID18484095. S2CID27812953.
Dakeishi M, Ohura T, Inoue K, Manabe M, Wada Y, Koizumi A, et al. (Jun 2001). "Homozygosity mapping to chromosome 5p15 of a gene responsible for Hartnup disorder". Biochemical and Biophysical Research Communications. 284 (2): 255–260. doi:10.1006/bbrc.2001.4961. PMID11394870.
Zhou C, Huang Y, Bu D, Zhu X, Jiang W, Zheng Y (Apr 2009). "A novel missense mutation in the SLC6A19 gene in a Chinese family with Hartnup disorder". International Journal of Dermatology. 48 (4): 388–392. doi:10.1111/j.1365-4632.2009.03989.x. PMID19335424. S2CID10229286.
Shirasaka Y, Fukushi A, Sato M, Nakamura T, Nakanishi T, Tamai I, et al. (Apr 2009). "Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells". Biopharmaceutics & Drug Disposition. 30 (3): 126–137. doi:10.1002/bdd.653. PMID19322909. S2CID20101533.
D, Rodgers H, Auray-Blais C, Giguère R, Bailey C, Bröer S, et al. (Nov 2007). "Persistence of the common Hartnup disease D173N allele in populations of European origin". Annals of Human Genetics. 71 (Pt 6): 755–761. doi:10.1111/j.1469-1809.2007.00375.x. PMID17555458. S2CID46125073.